Biolegend, 101337, Brilliant Violet 711™ anti-mouse CD16/32 Antibody
50microg
Catalog Number: 101337
Send a RFQ.
Category
Loading…
| Verified Reactivity | Mouse |
|---|---|
| Antibody Type | Monoclonal |
| Host Species | Rat |
| Immunogen | Sorted pre-B cells |
| Formulation | Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA). |
| Storage & Handling | The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze. |
| Application | FC - Quality tested |
| Recommended Usage | Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤0.25 µg per million cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.Brilliant Violet 711™ excites at 405 nm and emits at 711 nm. The bandpass filter 710/50 nm is recommended for detection, although filter optimization may be required depending on other fluorophores used. Be sure to verify that your cytometer configuration and software setup are appropriate for detecting this channel. Refer to your instrument manual or manufacturer for support. Brilliant Violet 711™ is a trademark of Sirigen Group Ltd.Learn more about Brilliant Violet™. This product is subject to proprietary rights of Sirigen Inc. and is made and sold under license from Sirigen Inc. The purchase of this product conveys to the buyer a non-transferable right to use the purchased product for research purposes only. This product may not be resold or incorporated in any manner into another product for resale. Any use for therapeutics or diagnostics is strictly prohibited. This product is covered by U.S. Patent(s), pending patent applications and foreign equivalents. |
| Excitation Laser | Violet Laser (405 nm) |
|---|
| Application Notes | Clone 93 can be used for blocking of CD16/CD32 interactions with the Fc domain of immunoglobulins, but is not the same clone as 2.4G2.The 93 mAb is specific to the common epitope of CD16/CD32. Additional reported applications (for the relevant formats) include: immunoprecipitation1 and blocking of Fc-mediated reactions in functional studies2,4,23. It is useful for blocking non-specific binding of immunoglobulin to Fc receptors. For blocking of Fc receptors in flow cytometric analysis, pre-incubate the cells with purified anti-CD16/CD32 antibody (=1.0 µg per 106 cells in 100 µL volume) for 5-10 minutes on ice prior to immunostaining. For highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 101330) (Endotoxin <0.01 EU/µg, Azide-Free, 0.2 µm filtered). |
|---|
| Application References(PubMed link indicates BioLegend citation) | Personal communication (IP) Oliver AM, et al. 1999. Hybridoma 18:113. (Block) Brummel R and Lenert P. 2005. J. Immunol. 174:2429. Terrazas LI, et al. 2005. Int. J. Parasitol. 35:1349. (Block) Clements JL, et al. 2006. J. Immunol. 177:905. Mohamed W, et al. 2010. Infect Immun. 78:3306. PubMed Ouchi T, et al. 2011. J. Exp Med. 208:2607. PubMed Kmieciak M, et al. 2011. J. Vis. Exp. 47:2381. PubMed Yamazaki S, et al. 2012. PLoS One. 7:e51665. PubMed Li J, et al. 2012. Arthritis Rheum. 64:1098. PubMed Azuma M, et al. 2012. Oncoimmunology. 1:581. PubMed Koon HW, et al. 2013. J. Vis. Exp. 68:4208. PubMed Hegde VL, et al. 2013. J Biol Chem. 288:36810. PubMed Huang J, et al. 2013. J. Immunol Methods. 387:254. PubMed Dutow P, et al. 2014. J Infect Dis. PubMed Fan Y, et al. 2014. J Exp Med. 211:313. PubMed Huang HN, et al. 2014. Antimicrob Agents Chemother. 58:1538. PubMed Takei S, et al. 2014. Vaccine. 32:3066. PubMed Richardson ML, et al. 2014. PLoS Negl Trop Dis. 8:2825. PubMed Cekanaviciute E, et al. 2014. J Immunol. 193:139. PubMed Kimura T, et al. 2014. Int Immunol. 26:697. PubMed Everad A, et al. 2014. Nat Commun. 5:5648. PubMed Cenci E, et al. 2006. J. Leuko. Biol. 79(1):40-5. (Block) |
|---|
| Product Citations | van Os BW, et al. 2023. Front Cardiovasc Med. 10:1171764. PubMed Duan H, et al. 2022. Adv Sci (Weinh). 9:e2103719. PubMed Pulous FE, et al. 2022. Nat Neurosci. 25:567. PubMed Schloss MJ, et al. 2022. Nat Immunol. 23:605. PubMed LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed Li Y, et al. 2020. Cell Stem Cell. 27(5):732-747.e7. PubMed Frodermann V, et al. 2019. Nat Med. 25:1761. PubMed Chen R, et al. 2021. Cell Reports. 34(7):108751. PubMed LeBlond ND, et al. 2020. J Lipid Res. 61:1697. PubMed Kim MY, et al. 2022. Nat Commun. 13:3296. PubMed Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed Chavez JS, et al. 2022. Cells. 11:. PubMed Heyde A, et al. 2021. Cell. 184(5):1348-1361.e22. PubMed Liu Q, et al. 2016. Cell Death Dis. 1.93125. PubMed Pessoa Rodrigues C, et al. 2020. Sci Adv. 6:eaaz4815. PubMed |
|---|
| RRID | AB_2565637 (BioLegend Cat. No. 101337) |
|---|
| Structure | Ig superfamily, 40-60 kD |
|---|
| Distribution | B cells, monocyte/macrophages, NK cells, neutrophils, mast cells, dendritic cells |
|---|
| Function | Low affinity receptors for IgG |
|---|
| Ligand/Receptor | IgG |
|---|
| Cell Type | B cells, Dendritic cells, Macrophages, Mast cells, Monocytes, Neutrophils, NK cells |
|---|
| Biology Area | Immunology, Innate Immunity |
|---|
| Molecular Family | CD Molecules, Fc Receptors |
|---|
| Antigen References | 1. Barclay AN, et al. 1997. The Leukocyte Antigen FactsBook Academic Press. 2. Unkeless JC. 1989. J. Clin. Invest. 83:355. 3. Qiu WQ, et al. 1990. Science 248:732. |
|---|
| Gene ID | 1413014131 |
|---|
| UniProt | View information about CD16/32 on UniProt.org |
|---|
| Clone | 93 |
|---|
| Regulatory Status | RUO |
|---|
| Other Names | Fcγ R III/II, Ly-17 |
|---|
| Isotype | Rat IgG2a, λ |
|---|
